THE COOPER COMPANIES, INC. The Cooper Companies, Inc. Stock BOERSE MUENCHEN
Equities
CP60
US2166485019
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.25 EUR | +4.43% |
|
-0.06% | +1.31% |
| 05-31 | Jefferies Adjusts Price Target on Cooper Companies to $107 From $105 | MT |
| 05-31 | Baird Adjusts Price Target on Cooper Companies to $118 From $116 | MT |
| Sales 2024 * | 3.88B 3.58B 5.29B | Sales 2025 * | 4.15B 3.82B 5.65B | Capitalization | 18.78B 17.32B 25.59B |
|---|---|---|---|---|---|
| Net income 2024 * | 452M 417M 616M | Net income 2025 * | 594M 548M 809M | EV / Sales 2024 * | 5.43 x |
| Net Debt 2024 * | 2.32B 2.14B 3.17B | Net Debt 2025 * | 1.7B 1.57B 2.31B | EV / Sales 2025 * | 4.94 x |
| P/E ratio 2024 * |
43.7
x | P/E ratio 2025 * |
31.2
x | Employees | - |
| Yield 2024 * |
0.06% | Yield 2025 * |
0.08% | Free-Float | 99.46% |
More Fundamentals
* Assessed data
More news
Latest transcript on The Cooper Companies, Inc.
More recommendations
More press releases
More news
| 1 week | -0.06% | ||
| 1 month | +4.55% | ||
| 3 months | +0.63% | ||
| 6 months | +13.31% | ||
| Current year | +1.31% |
1 week
83.55
87.95
1 month
82.4590.45
3 years
63.7897.95
| Managers | Title | Age | Since |
|---|---|---|---|
Albert White
CEO | Chief Executive Officer | 54 | 06-03-31 |
Robert Weiss
CHM | Chairman | 77 | 76-12-31 |
Brian Andrews
DFI | Director of Finance/CFO | 45 | 06-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Teresa Madden
BRD | Director/Board Member | 67 | 20-11-30 |
Lawrence Kurzius
BRD | Director/Board Member | 66 | 11-30 |
William Kozy
BRD | Director/Board Member | 72 | 16-03-31 |
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 87.25 | +4.43% |
| 24-05-30 | 83.55 | -0.89% |
| 24-05-29 | 84.3 | -0.41% |
| 24-05-28 | 84.65 | -2.70% |
| 24-05-27 | 87 | -0.34% |
Real-time BOERSE MUENCHEN, May 31, 2024 at 03:45 pm
More quotes
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Calendar
2024-06-05
- William Blair Growth Stock Conference
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
94.31
USD
Average target price
108.2
USD
Spread / Average Target
+14.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.39% | 43.96B | |
| -20.50% | 2.22B | |
| +25.60% | 2.11B | |
| +19.17% | 1.13B | |
| -38.32% | 716M | |
| -10.65% | 645M | |
| -44.53% | 632M | |
| +57.22% | 606M | |
| +17.51% | 494M |
- Stock Market
- Equities
- COO Stock
- CP60 Stock
